BofA/Merrill Lynch Downgrades Mednax (MD) to Underperform
Tweet
Share
E-mail
Get Alerts MD Hot Sheet
Price: $26.61 +0.91%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA/Merrill Lynch analyst Kevin Fischbeck downgraded Mednax (NYSE: MD) from Neutral to Underperform.
For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.
Shares of Mednax closed at $21.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- Brinker Int'l (EAT) PT Raised to $310 at BofA Securities
Create E-mail Alert Related Categories
DowngradesRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
